Home
IDT Biologika

IDT Biologika Market Share Analysis for August 2026

IDT Biologika is a global CDMO for Viral Vaccines, Gene & Immun Therapeutics and aseptic Fill-Finish of Sterile Injectables.

Health > Biotechnology and Pharmaceuticals

Domainidt-biologika.de

Year Founded1921

Employees1001 - 5000

Annual Revenue$200M - $500M

IDT Biologika

IDT Biologika (including company regionals)

idt-biologika.de

See more website traffic and engagement information

IDT Biologika Revenue up to August 2026 is 200M - 500M

revenue generated by IDT Biologika top domains

IDT Biologika top domains revenue over 3 years

Revenue for IDT Biologika top domains

idt-biologika.de200M - 500M

See more with Sales Intelligence

Total visits to IDT Biologika's top domains

Understand IDT Biologika market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

idt-biologika.de3.2K

See more with Sales Intelligence

Avg. visit duration in IDT Biologika's top domains

Analyze IDT Biologika engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

idt-biologika.de00:00:43

See more with Sales Intelligence

Avg. pageviews on IDT Biologika's top domains

See how IDT Biologika keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

idt-biologika.de2.24

See more with Sales Intelligence

IDT Biologika top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by IDT Biologika

These are the website technologies, by industry, used by IDT Biologika top domains

Conversion & Analytics (3)

Google Analytics

Marketing (3)

Google Marketing Platform

Payment & Currencies (3)

Euro

Social (3)

Instagram

More Technologies

7

See all

News & Signals from IDT Biologika

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIDT Biologika GmbH recognized as winner of CDMO Leadership Awards in each of the six categories Capabilities, Compatibility, Expertise, Quality, Reliability and Service.IDT Biologika, a leading contract development and manufacturing organization (CDMO) specialized in viral vaccines, viral vectors for cell and gene therapy as well as oncolytic viruses and other biologics, has been selected as a winner of CDMO Leadership Awards in each of the six categories Capabilities, Compatibility, Expertise, Quality, Reliability and Service in the group of respondents "Overall", which combines Big and Small Pharma.

NewsIDT Biologika GmbH partners with Jnjgermany.IDT Biologika, a global contract manufacturer of vaccines and active ingredients based in Dessau, also in Saxony-Anhalt, partnered with AstraZeneca and Johnson & Johnson to fill millions of vials with their viral vector vaccines against COVID-19.

NewsAstraZeneca GmbH partners with IDT Biologika GmbH.At the beginning, mainly nur... Read More LONDON -- Drugmaker AstraZeneca says it will work with German firm IDT Biologika to increase shipments of its COVID-19 vaccine to the European Union this spring following a heated dispute with the bloc over delayed vaccine deliveries.